Lassen Therapeutics to Present at the 5th Annual Idiopathic Pulmonary Fibrosis (IPF) Summit

SAN DIEGO–(BUSINESS WIRE)–Lassen Therapeutics, a biotech company developing innovative therapeutic antibodies as potential treatments for fibrosis, rare diseases and oncology, today announced that Jamie Swaney, Ph.D., Vice President of Fibrosis & Translational Biology, is presenting at the 5th Annual IPF Summit on Friday, August 27, 2021. The title of his presentation is “Antibody Mediated Blockade of Interleukin-11 Signaling for IPF and Other Fibrosing Lung Diseases”. Dr. Swaney will des
Click here to view original post